800-TEMPLE-MED Request Appointment
SEARCH TEMPLE HEALTH
Back To Doctor Search

Dina Ioffe, MD

Dina Ioffe
Request Appointment

  • Assistant Professor, Division of Gastrointestinal Medical Oncology

Specialties

Gastrointestinal Medical Oncology

Distinctions
Emblem for Hospitals that are High-Performing for Leukemia, Lymphoma, and Myeloma 2024-2025
4.7
54 Patient Satisfaction Ratings
About Me
Ratings & Reviews
Publications
About Me
Research Interests

Gastrointestinal Cancers, Hepatocellular Carcinoma, Geriatric Oncology, Translational Research, Quality Improvement, Health Disparities

Languages
  • Russian
  • English
Education
  • MD, University of Maryland School of Medicine, Baltimore, MD, 2017 
  • BA, Washington University in Saint Louis, St. Louis, MO, 2009

Postgraduate Education and Training

  • Fellow & Chief Fellow, Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, 2023 
  • Resident, Internal Medicine, University of Maryland Medical Center, Baltimore, MD, 2020 
Board Certifications
  • American Board of Internal Medicine - Internal Medicine
  • American Board of Internal Medicine - Medical Oncology
Memberships
  • American Society of Clinical Oncology (ASCO) 
  • American Society of Hematology (ASH) 
  • American Medical Association (AMA) 
  • Associate, American College of Physicians (ACP)
Awards and Honors
  • Elena Gitelson Chief Fellow Award, 2023 
  • Clinician-Scientists Transdisciplinary Aging Research (Clin-STAR) Pilot Grant Award Recipient, 2023 
  • Fox Chase Cancer Center In Vino Vita Young Investigator Award, 2022 
  • ASCO Quality Training Program (QTP), Selected Participant, 2022 
No video provider was found to handle the given URL. See the documentation for more information.
  • Elena Gitelson Chief Fellow Award, 2023 
  • Clinician-Scientists Transdisciplinary Aging Research (Clin-STAR) Pilot Grant Award Recipient, 2023 
  • Fox Chase Cancer Center In Vino Vita Young Investigator Award, 2022 
  • ASCO Quality Training Program (QTP), Selected Participant, 2022 
Ratings & Reviews

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Overall Care
4.7
Explained Things Clearly
4.6
Showed Courtesy & Respect
4.8
Discussed Treatment Options
4.6
Recommend Provider
4.9

Patient Comments

4.7 out of 5 (54 ratings, 8 comments)
05/27/2026

Good

02/20/2026

Dr. Ioffe is very thorough. She takes time to answer my questions and I never feel rushed. Excellent bedside manner. Love her!

09/08/2025

There wasn't much of an opportunity to discuss what is important in my life during this appointment, but I still came away with the impression that my provider(s) understood my priorities.

08/25/2025

There was no discussion of risks during this visit.

05/28/2025

Very happy with the provider and facilities.

Offices

Office Locations

Fox Chase Cancer Center

333 Cottman Avenue

Philadelphia, PA 19111

Phone: 888-369-2427

Fox Chase Cancer Center at Temple University Hospital

3401 N. Broad Street

Philadelphia, PA 19140

Phone: 888-369-2427

Publications
Publications

My NCBI

  1. Ioffe D, Dotan E. Evidence-Based Care of Older Adults With Metastatic Colorectal Cancer: Insights From Landmark Clinical Trials. J Clin Oncol. 2023 Oct 19:JCO2301337. doi: 10.1200/JCO.23.01337. Epub ahead of print. PMID: 37856768.  
  2. Ioffe D, McSweeny M, Hall MJ. Precision Medicine in the Era of Genetic Testing: Microsatellite Instability Evolved. Clin Colon Rectal Surg. 2023 July. doi: 10.1055/s-0043-1770385. 
  3. Dotan E, Catalano P, Lenchik L, Boutin R, Yao X, Marques HS, Ioffe D, Zhen DB, Li D, Wagner LI, Simon MA, Wong TZ, O'Dwyer PJ. The GIANT trial (ECOG-ACRIN EA2186) methods paper: A randomized phase II study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and liposomal irinotecan in older patients with treatment-naïve metastatic pancreatic cancer - defining a new treatment option for older vulnerable patients. J Geriatr Oncol. 2023 Apr;14(3):101474. doi: 10.1016/j.jgo.2023.101474. Epub 2023 Mar 22. PMID: 36963200. 
  4. Ioffe D, Dotan E. Guidance for Treating the Older Adults with Colorectal Cancer. Curr Treat Options Oncol. 2023 Jun;24(6):644-666. doi: 10.1007/s11864-023-01071-6. Epub 2023 Apr 13. PMID: 37052812. 
  5. Ioffe D, Phull P, Dotan E. Optimal Management of Patients with Advanced or Metastatic Cholangiocarcinoma: An Evidence-Based Review. Cancer Manag Res. 2021 Oct 27;13:8085-8098. doi: 10.2147/CMAR.S276104. PMID: 34737637; PMCID: PMC8558827. 
  6. Amr S, Ioffe D, Suzuki I, Mehra R, Cullen K, Goloubeva O. Treatment modalities, adverse events, and survival outcomes in older patients with head and neck squamous cell carcinoma. Head Neck. 2021 Dec;43(12):3935-3945. doi: 10.1002/hed.26893. Epub 2021 Oct 10. PMID: 34632677. 
  7. Lin J, Nichols E, Kesmodel SB, Ioffe D, Ioffe O, Tkaczuk KHR. Chapter 3: Phyllodes Tumor. In: Tkaczuk KHR (ed). Handbook of Breast Cancer and Related Breast Disease. Demos Medical Publishing, 1st Edition, 2016: 39-48.